1996
DOI: 10.1002/(sici)1098-1004(1996)7:1<85::aid-humu17>3.3.co;2-m
|View full text |Cite
|
Sign up to set email alerts
|

Recurrent 2‐bp deletion in exon 10c of the NF1 gene in two cases of von Recklinghausen neurofibromatosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

1998
1998
2001
2001

Publication Types

Select...
3

Relationship

2
1

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…The other mutations are new. The mutation D176E is the second change identified in the NF1 gene of patient 0545, who has already been reported to be a carrier of the disease-causing mutation 1541delAG [17]. Therefore, we interpret D176E as a rare polymorphism.…”
mentioning
confidence: 74%
“…The other mutations are new. The mutation D176E is the second change identified in the NF1 gene of patient 0545, who has already been reported to be a carrier of the disease-causing mutation 1541delAG [17]. Therefore, we interpret D176E as a rare polymorphism.…”
mentioning
confidence: 74%
“…The genetic basis of the disease is a mutation located on chromosome 17q11.2 (1). Although recently a wide variety of genetic mutations has been described (2)(3)(4), no frequently recurring mutation has been identified, and diagnosis is still based on established clinical criteria (5). The "classic triad" of symptoms is: cafè-au-lait spots (brown skin pigmentation), cutaneous neurofibromas, and neoplasms of the peripheral or central nervous system.…”
mentioning
confidence: 99%
“…Primer sequences and polymerase chain reaction (PCR) conditions are given in Table 1. TGGE was performed as described by Robinson et al (1996). cDNA was synthesized with the Superscript preamplification system (Gibco BRL, USA) using total RNA (Chomczynsky and Sacchi 1987).…”
Section: Methodsmentioning
confidence: 99%